Global Blood Glucose Monitoring System (BGMS) Market Research Report 2022
Global Blood Glucose Monitoring System (BGMS) Market Overview:
Global Blood Glucose Monitoring System (BGMS) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Blood Glucose Monitoring System (BGMS) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Blood Glucose Monitoring System (BGMS) Market
The Blood Glucose Monitoring System (BGMS) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Blood Glucose Monitoring System (BGMS) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Blood Glucose Monitoring System (BGMS) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Blood Glucose Monitoring System (BGMS) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Blood Glucose Monitoring System (BGMS) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Blood Glucose Monitoring System (BGMS) Market Segmentation
Global Blood Glucose Monitoring System (BGMS) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Blood Glucose Monitoring System (BGMS) market has been segmented into:
Blood Glucose Test Strips
Blood Glucose Meter
By Application, Blood Glucose Monitoring System (BGMS) market has been segmented into:
Hospital
Household
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Blood Glucose Monitoring System (BGMS) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Blood Glucose Monitoring System (BGMS) market.
Top Key Players Covered in Blood Glucose Monitoring System (BGMS) market are:
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Sinocare
Yicheng
Yuwell
Acon
Other Major Players
Objective to buy this Report:
1. Blood Glucose Monitoring System (BGMS) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Blood Glucose Monitoring System (BGMS) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Blood Glucose Monitoring System (BGMS) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Blood Glucose Monitoring System (BGMS) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Blood Glucose Monitoring System (BGMS) Market
The Blood Glucose Monitoring System (BGMS) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Blood Glucose Monitoring System (BGMS) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Blood Glucose Monitoring System (BGMS) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Blood Glucose Monitoring System (BGMS) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Blood Glucose Monitoring System (BGMS) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Blood Glucose Monitoring System (BGMS) Market Segmentation
Global Blood Glucose Monitoring System (BGMS) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Blood Glucose Monitoring System (BGMS) market has been segmented into:
Blood Glucose Test Strips
Blood Glucose Meter
By Application, Blood Glucose Monitoring System (BGMS) market has been segmented into:
Hospital
Household
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Blood Glucose Monitoring System (BGMS) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Blood Glucose Monitoring System (BGMS) market.
Top Key Players Covered in Blood Glucose Monitoring System (BGMS) market are:
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Sinocare
Yicheng
Yuwell
Acon
Other Major Players
Objective to buy this Report:
1. Blood Glucose Monitoring System (BGMS) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Blood Glucose Monitoring System (BGMS) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 RESEARCH OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.3 RESEARCH PROCESS
1.4 SCOPE AND COVERAGE
1.4.1 MARKET DEFINITION
1.4.2 KEY QUESTIONS ANSWERED
1.5 MARKET SEGMENTATION
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 BY TYPE
3.2 BY APPLICATION
CHAPTER 4: MARKET LANDSCAPE
4.1 PORTER'S FIVE FORCES ANALYSIS
4.1.1 BARGAINING POWER OF SUPPLIER
4.1.2 THREAT OF NEW ENTRANTS
4.1.3 THREAT OF SUBSTITUTES
4.1.4 COMPETITIVE RIVALRY
4.1.5 BARGAINING POWER AMONG BUYERS
4.2 INDUSTRY VALUE CHAIN ANALYSIS
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 OPPORTUNITIES
4.5.4 CHALLENGES
4.4 PESTLE ANALYSIS
4.5 TECHNOLOGICAL ROADMAP
4.6 REGULATORY LANDSCAPE
4.7 SWOT ANALYSIS
4.8 PRICE TREND ANALYSIS
4.9 PATENT ANALYSIS
4.10 ANALYSIS OF THE IMPACT OF COVID-19
4.10.1 IMPACT ON THE OVERALL MARKET
4.10.2 IMPACT ON THE SUPPLY CHAIN
4.10.3 IMPACT ON THE KEY MANUFACTURERS
4.10.4 IMPACT ON THE PRICING
CHAPTER 5: BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY TYPE
5.1 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
5.2 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW
5.3 BLOOD GLUCOSE TEST STRIPS
5.3.1 INTRODUCTION AND MARKET OVERVIEW
5.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.3.4 BLOOD GLUCOSE TEST STRIPS: GEOGRAPHIC SEGMENTATION
5.4 BLOOD GLUCOSE METER
5.4.1 INTRODUCTION AND MARKET OVERVIEW
5.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.4.4 BLOOD GLUCOSE METER : GEOGRAPHIC SEGMENTATION
CHAPTER 6: BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY APPLICATION
6.1 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
6.2 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW
6.3 HOSPITAL
6.3.1 INTRODUCTION AND MARKET OVERVIEW
6.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.3.4 HOSPITAL: GEOGRAPHIC SEGMENTATION
6.4 HOUSEHOLD
6.4.1 INTRODUCTION AND MARKET OVERVIEW
6.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.4.4 HOUSEHOLD : GEOGRAPHIC SEGMENTATION
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 COMPETITIVE LANDSCAPE
7.1.1 COMPETITIVE POSITIONING
7.1.2 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) SALES AND MARKET SHARE BY PLAYERS
7.1.3 INDUSTRY BCG MATRIX
7.1.4 HEAT MAP ANALYSIS
7.1.5 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) INDUSTRY CONCENTRATION RATIO (CR5 AND HHI)
7.1.6 TOP 5 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) PLAYERS MARKET SHARE
7.1.7 MERGERS AND ACQUISITIONS
7.1.8 BUSINESS STRATEGIES BY TOP PLAYERS
7.2 ROCHE
7.2.1 COMPANY OVERVIEW
7.2.2 KEY EXECUTIVES
7.2.3 COMPANY SNAPSHOT
7.2.4 OPERATING BUSINESS SEGMENTS
7.2.5 PRODUCT PORTFOLIO
7.2.6 BUSINESS PERFORMANCE
7.2.7 KEY STRATEGIC MOVES AND RECENT DEVELOPMENTS
7.2.8 SWOT ANALYSIS
7.3 LIFESCAN
7.4 ABBOTT
7.5 ASCENSIA
7.6 ARKRAY
7.7 I-SENS
7.8 OMRON
7.9 B. BRAUN
7.10 77 ELEKTRONIKA
7.11 AGAMATRIX
7.12 ALL MEDICUS
7.13 TERUMO
7.14 SINOCARE
7.15 YICHENG
7.16 YUWELL
7.17 ACON
7.18 OTHER MAJOR PLAYERS
CHAPTER 8: GLOBAL BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 MARKET OVERVIEW
8.2 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
8.2.1 BLOOD GLUCOSE TEST STRIPS
8.2.2 BLOOD GLUCOSE METER
8.3 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
8.3.1 HOSPITAL
8.3.2 HOUSEHOLD
CHAPTER 9: NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.2 IMPACT OF COVID-19
9.3 KEY PLAYERS
9.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
9.4.1 BLOOD GLUCOSE TEST STRIPS
9.4.2 BLOOD GLUCOSE METER
9.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
9.5.1 HOSPITAL
9.5.2 HOUSEHOLD
9.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
9.6.1 U.S.
9.6.2 CANADA
9.6.3 MEXICO
CHAPTER 10: EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.2 IMPACT OF COVID-19
10.3 KEY PLAYERS
10.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
10.4.1 BLOOD GLUCOSE TEST STRIPS
10.4.2 BLOOD GLUCOSE METER
10.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
10.5.1 HOSPITAL
10.5.2 HOUSEHOLD
10.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
10.6.1 GERMANY
10.6.2 U.K.
10.6.3 FRANCE
10.6.4 ITALY
10.6.5 RUSSIA
10.6.6 SPAIN
10.6.7 REST OF EUROPE
CHAPTER 11: ASIA-PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.2 IMPACT OF COVID-19
11.3 KEY PLAYERS
11.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
11.4.1 BLOOD GLUCOSE TEST STRIPS
11.4.2 BLOOD GLUCOSE METER
11.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
11.5.1 HOSPITAL
11.5.2 HOUSEHOLD
11.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
11.6.1 CHINA
11.6.2 INDIA
11.6.3 JAPAN
11.6.4 SINGAPORE
11.6.5 AUSTRALIA
11.6.6 NEW ZEALAND
11.6.7 REST OF APAC
CHAPTER 12: MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.2 IMPACT OF COVID-19
12.3 KEY PLAYERS
12.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
12.4.1 BLOOD GLUCOSE TEST STRIPS
12.4.2 BLOOD GLUCOSE METER
12.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
12.5.1 HOSPITAL
12.5.2 HOUSEHOLD
12.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
12.6.1 TURKEY
12.6.2 SAUDI ARABIA
12.6.3 IRAN
12.6.4 UAE
12.6.5 AFRICA
12.6.6 REST OF MEA
CHAPTER 13: SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.2 IMPACT OF COVID-19
13.3 KEY PLAYERS
13.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
13.4.1 BLOOD GLUCOSE TEST STRIPS
13.4.2 BLOOD GLUCOSE METER
13.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
13.5.1 HOSPITAL
13.5.2 HOUSEHOLD
13.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
13.6.1 BRAZIL
13.6.2 ARGENTINA
13.6.3 REST OF SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 RESEARCH OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.3 RESEARCH PROCESS
1.4 SCOPE AND COVERAGE
1.4.1 MARKET DEFINITION
1.4.2 KEY QUESTIONS ANSWERED
1.5 MARKET SEGMENTATION
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 BY TYPE
3.2 BY APPLICATION
CHAPTER 4: MARKET LANDSCAPE
4.1 PORTER'S FIVE FORCES ANALYSIS
4.1.1 BARGAINING POWER OF SUPPLIER
4.1.2 THREAT OF NEW ENTRANTS
4.1.3 THREAT OF SUBSTITUTES
4.1.4 COMPETITIVE RIVALRY
4.1.5 BARGAINING POWER AMONG BUYERS
4.2 INDUSTRY VALUE CHAIN ANALYSIS
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 OPPORTUNITIES
4.5.4 CHALLENGES
4.4 PESTLE ANALYSIS
4.5 TECHNOLOGICAL ROADMAP
4.6 REGULATORY LANDSCAPE
4.7 SWOT ANALYSIS
4.8 PRICE TREND ANALYSIS
4.9 PATENT ANALYSIS
4.10 ANALYSIS OF THE IMPACT OF COVID-19
4.10.1 IMPACT ON THE OVERALL MARKET
4.10.2 IMPACT ON THE SUPPLY CHAIN
4.10.3 IMPACT ON THE KEY MANUFACTURERS
4.10.4 IMPACT ON THE PRICING
CHAPTER 5: BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY TYPE
5.1 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
5.2 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW
5.3 BLOOD GLUCOSE TEST STRIPS
5.3.1 INTRODUCTION AND MARKET OVERVIEW
5.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.3.4 BLOOD GLUCOSE TEST STRIPS: GEOGRAPHIC SEGMENTATION
5.4 BLOOD GLUCOSE METER
5.4.1 INTRODUCTION AND MARKET OVERVIEW
5.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.4.4 BLOOD GLUCOSE METER : GEOGRAPHIC SEGMENTATION
CHAPTER 6: BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY APPLICATION
6.1 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
6.2 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW
6.3 HOSPITAL
6.3.1 INTRODUCTION AND MARKET OVERVIEW
6.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.3.4 HOSPITAL: GEOGRAPHIC SEGMENTATION
6.4 HOUSEHOLD
6.4.1 INTRODUCTION AND MARKET OVERVIEW
6.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.4.4 HOUSEHOLD : GEOGRAPHIC SEGMENTATION
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 COMPETITIVE LANDSCAPE
7.1.1 COMPETITIVE POSITIONING
7.1.2 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) SALES AND MARKET SHARE BY PLAYERS
7.1.3 INDUSTRY BCG MATRIX
7.1.4 HEAT MAP ANALYSIS
7.1.5 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) INDUSTRY CONCENTRATION RATIO (CR5 AND HHI)
7.1.6 TOP 5 BLOOD GLUCOSE MONITORING SYSTEM (BGMS) PLAYERS MARKET SHARE
7.1.7 MERGERS AND ACQUISITIONS
7.1.8 BUSINESS STRATEGIES BY TOP PLAYERS
7.2 ROCHE
7.2.1 COMPANY OVERVIEW
7.2.2 KEY EXECUTIVES
7.2.3 COMPANY SNAPSHOT
7.2.4 OPERATING BUSINESS SEGMENTS
7.2.5 PRODUCT PORTFOLIO
7.2.6 BUSINESS PERFORMANCE
7.2.7 KEY STRATEGIC MOVES AND RECENT DEVELOPMENTS
7.2.8 SWOT ANALYSIS
7.3 LIFESCAN
7.4 ABBOTT
7.5 ASCENSIA
7.6 ARKRAY
7.7 I-SENS
7.8 OMRON
7.9 B. BRAUN
7.10 77 ELEKTRONIKA
7.11 AGAMATRIX
7.12 ALL MEDICUS
7.13 TERUMO
7.14 SINOCARE
7.15 YICHENG
7.16 YUWELL
7.17 ACON
7.18 OTHER MAJOR PLAYERS
CHAPTER 8: GLOBAL BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 MARKET OVERVIEW
8.2 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
8.2.1 BLOOD GLUCOSE TEST STRIPS
8.2.2 BLOOD GLUCOSE METER
8.3 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
8.3.1 HOSPITAL
8.3.2 HOUSEHOLD
CHAPTER 9: NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.2 IMPACT OF COVID-19
9.3 KEY PLAYERS
9.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
9.4.1 BLOOD GLUCOSE TEST STRIPS
9.4.2 BLOOD GLUCOSE METER
9.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
9.5.1 HOSPITAL
9.5.2 HOUSEHOLD
9.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
9.6.1 U.S.
9.6.2 CANADA
9.6.3 MEXICO
CHAPTER 10: EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.2 IMPACT OF COVID-19
10.3 KEY PLAYERS
10.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
10.4.1 BLOOD GLUCOSE TEST STRIPS
10.4.2 BLOOD GLUCOSE METER
10.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
10.5.1 HOSPITAL
10.5.2 HOUSEHOLD
10.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
10.6.1 GERMANY
10.6.2 U.K.
10.6.3 FRANCE
10.6.4 ITALY
10.6.5 RUSSIA
10.6.6 SPAIN
10.6.7 REST OF EUROPE
CHAPTER 11: ASIA-PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.2 IMPACT OF COVID-19
11.3 KEY PLAYERS
11.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
11.4.1 BLOOD GLUCOSE TEST STRIPS
11.4.2 BLOOD GLUCOSE METER
11.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
11.5.1 HOSPITAL
11.5.2 HOUSEHOLD
11.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
11.6.1 CHINA
11.6.2 INDIA
11.6.3 JAPAN
11.6.4 SINGAPORE
11.6.5 AUSTRALIA
11.6.6 NEW ZEALAND
11.6.7 REST OF APAC
CHAPTER 12: MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.2 IMPACT OF COVID-19
12.3 KEY PLAYERS
12.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
12.4.1 BLOOD GLUCOSE TEST STRIPS
12.4.2 BLOOD GLUCOSE METER
12.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
12.5.1 HOSPITAL
12.5.2 HOUSEHOLD
12.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
12.6.1 TURKEY
12.6.2 SAUDI ARABIA
12.6.3 IRAN
12.6.4 UAE
12.6.5 AFRICA
12.6.6 REST OF MEA
CHAPTER 13: SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.2 IMPACT OF COVID-19
13.3 KEY PLAYERS
13.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
13.4.1 BLOOD GLUCOSE TEST STRIPS
13.4.2 BLOOD GLUCOSE METER
13.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
13.5.1 HOSPITAL
13.5.2 HOUSEHOLD
13.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
13.6.1 BRAZIL
13.6.2 ARGENTINA
13.6.3 REST OF SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET COMPETITIVE RIVALRY
TABLE 005. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET THREAT OF NEW ENTRANTS
TABLE 006. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET THREAT OF SUBSTITUTES
TABLE 007. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY TYPE
TABLE 008. BLOOD GLUCOSE TEST STRIPS MARKET OVERVIEW (2016-2028)
TABLE 009. BLOOD GLUCOSE METER MARKET OVERVIEW (2016-2028)
TABLE 010. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY APPLICATION
TABLE 011. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 012. HOUSEHOLD MARKET OVERVIEW (2016-2028)
TABLE 013. NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 014. NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 015. N BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 016. EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 017. EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 018. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 019. ASIA PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 020. ASIA PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 021. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 022. MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 024. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 025. SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 026. SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 027. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 028. ROCHE: SNAPSHOT
TABLE 029. ROCHE: BUSINESS PERFORMANCE
TABLE 030. ROCHE: PRODUCT PORTFOLIO
TABLE 031. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 031. LIFESCAN: SNAPSHOT
TABLE 032. LIFESCAN: BUSINESS PERFORMANCE
TABLE 033. LIFESCAN: PRODUCT PORTFOLIO
TABLE 034. LIFESCAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. ABBOTT: SNAPSHOT
TABLE 035. ABBOTT: BUSINESS PERFORMANCE
TABLE 036. ABBOTT: PRODUCT PORTFOLIO
TABLE 037. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. ASCENSIA: SNAPSHOT
TABLE 038. ASCENSIA: BUSINESS PERFORMANCE
TABLE 039. ASCENSIA: PRODUCT PORTFOLIO
TABLE 040. ASCENSIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. ARKRAY: SNAPSHOT
TABLE 041. ARKRAY: BUSINESS PERFORMANCE
TABLE 042. ARKRAY: PRODUCT PORTFOLIO
TABLE 043. ARKRAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. I-SENS: SNAPSHOT
TABLE 044. I-SENS: BUSINESS PERFORMANCE
TABLE 045. I-SENS: PRODUCT PORTFOLIO
TABLE 046. I-SENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. OMRON: SNAPSHOT
TABLE 047. OMRON: BUSINESS PERFORMANCE
TABLE 048. OMRON: PRODUCT PORTFOLIO
TABLE 049. OMRON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. B. BRAUN: SNAPSHOT
TABLE 050. B. BRAUN: BUSINESS PERFORMANCE
TABLE 051. B. BRAUN: PRODUCT PORTFOLIO
TABLE 052. B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. 77 ELEKTRONIKA: SNAPSHOT
TABLE 053. 77 ELEKTRONIKA: BUSINESS PERFORMANCE
TABLE 054. 77 ELEKTRONIKA: PRODUCT PORTFOLIO
TABLE 055. 77 ELEKTRONIKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. AGAMATRIX: SNAPSHOT
TABLE 056. AGAMATRIX: BUSINESS PERFORMANCE
TABLE 057. AGAMATRIX: PRODUCT PORTFOLIO
TABLE 058. AGAMATRIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. ALL MEDICUS: SNAPSHOT
TABLE 059. ALL MEDICUS: BUSINESS PERFORMANCE
TABLE 060. ALL MEDICUS: PRODUCT PORTFOLIO
TABLE 061. ALL MEDICUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. TERUMO: SNAPSHOT
TABLE 062. TERUMO: BUSINESS PERFORMANCE
TABLE 063. TERUMO: PRODUCT PORTFOLIO
TABLE 064. TERUMO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. SINOCARE: SNAPSHOT
TABLE 065. SINOCARE: BUSINESS PERFORMANCE
TABLE 066. SINOCARE: PRODUCT PORTFOLIO
TABLE 067. SINOCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. YICHENG: SNAPSHOT
TABLE 068. YICHENG: BUSINESS PERFORMANCE
TABLE 069. YICHENG: PRODUCT PORTFOLIO
TABLE 070. YICHENG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. YUWELL: SNAPSHOT
TABLE 071. YUWELL: BUSINESS PERFORMANCE
TABLE 072. YUWELL: PRODUCT PORTFOLIO
TABLE 073. YUWELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. ACON: SNAPSHOT
TABLE 074. ACON: BUSINESS PERFORMANCE
TABLE 075. ACON: PRODUCT PORTFOLIO
TABLE 076. ACON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 077. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 078. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 079. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET COMPETITIVE RIVALRY
TABLE 005. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET THREAT OF NEW ENTRANTS
TABLE 006. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET THREAT OF SUBSTITUTES
TABLE 007. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY TYPE
TABLE 008. BLOOD GLUCOSE TEST STRIPS MARKET OVERVIEW (2016-2028)
TABLE 009. BLOOD GLUCOSE METER MARKET OVERVIEW (2016-2028)
TABLE 010. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET BY APPLICATION
TABLE 011. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 012. HOUSEHOLD MARKET OVERVIEW (2016-2028)
TABLE 013. NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 014. NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 015. N BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 016. EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 017. EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 018. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 019. ASIA PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 020. ASIA PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 021. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 022. MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 023. MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 024. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 025. SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY TYPE (2016-2028)
TABLE 026. SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY APPLICATION (2016-2028)
TABLE 027. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET, BY COUNTRY (2016-2028)
TABLE 028. ROCHE: SNAPSHOT
TABLE 029. ROCHE: BUSINESS PERFORMANCE
TABLE 030. ROCHE: PRODUCT PORTFOLIO
TABLE 031. ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 031. LIFESCAN: SNAPSHOT
TABLE 032. LIFESCAN: BUSINESS PERFORMANCE
TABLE 033. LIFESCAN: PRODUCT PORTFOLIO
TABLE 034. LIFESCAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 034. ABBOTT: SNAPSHOT
TABLE 035. ABBOTT: BUSINESS PERFORMANCE
TABLE 036. ABBOTT: PRODUCT PORTFOLIO
TABLE 037. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. ASCENSIA: SNAPSHOT
TABLE 038. ASCENSIA: BUSINESS PERFORMANCE
TABLE 039. ASCENSIA: PRODUCT PORTFOLIO
TABLE 040. ASCENSIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. ARKRAY: SNAPSHOT
TABLE 041. ARKRAY: BUSINESS PERFORMANCE
TABLE 042. ARKRAY: PRODUCT PORTFOLIO
TABLE 043. ARKRAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. I-SENS: SNAPSHOT
TABLE 044. I-SENS: BUSINESS PERFORMANCE
TABLE 045. I-SENS: PRODUCT PORTFOLIO
TABLE 046. I-SENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. OMRON: SNAPSHOT
TABLE 047. OMRON: BUSINESS PERFORMANCE
TABLE 048. OMRON: PRODUCT PORTFOLIO
TABLE 049. OMRON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. B. BRAUN: SNAPSHOT
TABLE 050. B. BRAUN: BUSINESS PERFORMANCE
TABLE 051. B. BRAUN: PRODUCT PORTFOLIO
TABLE 052. B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. 77 ELEKTRONIKA: SNAPSHOT
TABLE 053. 77 ELEKTRONIKA: BUSINESS PERFORMANCE
TABLE 054. 77 ELEKTRONIKA: PRODUCT PORTFOLIO
TABLE 055. 77 ELEKTRONIKA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. AGAMATRIX: SNAPSHOT
TABLE 056. AGAMATRIX: BUSINESS PERFORMANCE
TABLE 057. AGAMATRIX: PRODUCT PORTFOLIO
TABLE 058. AGAMATRIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. ALL MEDICUS: SNAPSHOT
TABLE 059. ALL MEDICUS: BUSINESS PERFORMANCE
TABLE 060. ALL MEDICUS: PRODUCT PORTFOLIO
TABLE 061. ALL MEDICUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. TERUMO: SNAPSHOT
TABLE 062. TERUMO: BUSINESS PERFORMANCE
TABLE 063. TERUMO: PRODUCT PORTFOLIO
TABLE 064. TERUMO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. SINOCARE: SNAPSHOT
TABLE 065. SINOCARE: BUSINESS PERFORMANCE
TABLE 066. SINOCARE: PRODUCT PORTFOLIO
TABLE 067. SINOCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. YICHENG: SNAPSHOT
TABLE 068. YICHENG: BUSINESS PERFORMANCE
TABLE 069. YICHENG: PRODUCT PORTFOLIO
TABLE 070. YICHENG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. YUWELL: SNAPSHOT
TABLE 071. YUWELL: BUSINESS PERFORMANCE
TABLE 072. YUWELL: PRODUCT PORTFOLIO
TABLE 073. YUWELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. ACON: SNAPSHOT
TABLE 074. ACON: BUSINESS PERFORMANCE
TABLE 075. ACON: PRODUCT PORTFOLIO
TABLE 076. ACON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 077. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 078. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 079. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY TYPE
FIGURE 012. BLOOD GLUCOSE TEST STRIPS MARKET OVERVIEW (2016-2028)
FIGURE 013. BLOOD GLUCOSE METER MARKET OVERVIEW (2016-2028)
FIGURE 014. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY APPLICATION
FIGURE 015. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 016. HOUSEHOLD MARKET OVERVIEW (2016-2028)
FIGURE 017. NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 018. EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. ASIA PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY TYPE
FIGURE 012. BLOOD GLUCOSE TEST STRIPS MARKET OVERVIEW (2016-2028)
FIGURE 013. BLOOD GLUCOSE METER MARKET OVERVIEW (2016-2028)
FIGURE 014. BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY APPLICATION
FIGURE 015. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 016. HOUSEHOLD MARKET OVERVIEW (2016-2028)
FIGURE 017. NORTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 018. EUROPE BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 019. ASIA PACIFIC BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. SOUTH AMERICA BLOOD GLUCOSE MONITORING SYSTEM (BGMS) MARKET OVERVIEW BY COUNTRY (2016-2028)
